Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.

As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.

The messenger RNA (mRNA) market is undergoing significant expansion, driven by its versatile approach in treating and ...

New partnership targets foot-and-mouth disease with scalable, next-generation technology A new global collaboration is aiming to bring next-generation RNA vaccine technology into livestock health, as ...

Learn how messenger RNA, spike protein, and lipid nanoparticles drive rapid advances in vaccines and cancer therapies, reshaping modern medicine with precision and speed. Pixabay, spencerbdavis1 ...

Washington — U.S. Food and Drug Administration Commissioner Marty Makary on Monday defended his agency's position and record on mRNA vaccines, days after it changed course and agreed to review a ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice within hours. (Nanowerk Spotlight) Messenger RNA (mRNA) vaccines ...

As Zika cases continue to rise around the world — and in the United States — with associated increases in Guillain-Barre syndrome and congenital birth defects, the need for a safe and effective ...

PARIS (Reuters) - France's top health body will on Friday say that recipients of a first dose of AstraZeneca's traditional COVID-19 vaccine who are under 55 should get a second shot with a new-style ...